bioMérieux, Inc. is a global leader in in vitro diagnostics, specializing in the development, manufacturing, and marketing of diagnostic solutions for medical and industrial applications. The company generates revenue by providing innovative diagnostic tools and services that help detect and manage infectious diseases, cancer, and cardiovascular conditions, as well as ensuring food and pharmaceutical safety. Founded in 1963 by Alain Mérieux, bioMérieux has a rich history of pioneering diagnostic advancements and is part of the Institut Mérieux group, which focuses on public health.